title: Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Makowsky
authors.forename: Dawn I
authors.initials: DI
authors.lastname: Warkentin
authors.forename: M Lynn
authors.initials: ML
authors.lastname: Savoie
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077336:Caspofungin; D054714:Echinocandins; D017809:Fatal Outcome; D005670:Fusarium; D006801:Humans; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000188:drug therapy* / Q000382:microbiology; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*; D016879:Salvage Therapy
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin